Patents by Inventor W. Robert Addington

W. Robert Addington has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7264553
    Abstract: A method of using a bowler's aid on the fingers inserted into the finger grip holes of the bowling ball and used to hold the ball. The bowler's aid is mounted on the finger or hand of the bowler by means of a fastening means. When the bowler's aid is in place, a finger pad finger pad shield is placed opposite the finger pad which may be connected to a load bearing means by a support means. The finger pad finger pad shield assists the bowler in using his or her natural force in the finger against the ball, for example when lifting the ball in its delivery, or in meeting the force of the ball against the finger. The bowler's aid may include a depth limiting means to control the depth of the bowler's finger in the hole of the bowling ball.
    Type: Grant
    Filed: September 15, 1999
    Date of Patent: September 4, 2007
    Inventors: Randall A. Addington, W. Robert Addington, W. Robert Addington, II
  • Patent number: 6938274
    Abstract: An adjustable tensioning strap is mounted in a glove worn on the bowling hand and connecting the glove finger tip and an anchor point proximate the wrist or palm. The tensioning strap, from the finger tip to the anchor point, is held adjacent the glove lining by one or more transverse support straps so when placed on the hand and with tension applied to the tensioning strap, the tensioning strap is held or forced by the transverse support straps toward and substantially adjacent the bowler's finger and palm.
    Type: Grant
    Filed: November 18, 2003
    Date of Patent: September 6, 2005
    Inventors: Randall A. Addington, W. Robert Addington, II
  • Publication number: 20040181161
    Abstract: An apparatus and method for evaluating a patient's laryngeal cough reflex function includes a nebulizer capable of being actuated to atomize a cough-inducing substance, a switch associated with the nebulizer, the switch responsive to actuation of the nebulizer, and a connection between the switch and an EMG machine to thereby activate the EMG machine responsive to the switch. Elapsed time between switch actuation and electrical activity sensed in a muscle which contracts to produce a cough is indicative of status of the patient's laryngeal cough reflex.
    Type: Application
    Filed: February 20, 2004
    Publication date: September 16, 2004
    Inventors: W. Robert Addington, Stuart Miller, Robert Stephens
  • Publication number: 20040172010
    Abstract: A apparatus and method for self-treatment of cardiac arrhythmia by a patient, comprising a container sized to be portable by the patient and having therein a chamber containing a medicament composition comprising a pharmaceutically acceptable carrier mixed with a chemoirritant, preferably L-tartaric acid; a nebulizing valve connected to the chamber so as to provide an outlet therefor, a source of motivating force connected with the chamber so as to motivate the composition through the opening in the nebulizing valve to thereby cause nebulization of the composition; a wireless transmitter responsive to activation of the nebulizer for sending a wireless signal requesting medical assistance; and a power source operatively connected for providing power; wherein the chemoirritant is mixed in the composition in an amount sufficient for causing the patient to produce an involuntary cough effective to maintain at least partial blood circulation.
    Type: Application
    Filed: January 13, 2004
    Publication date: September 2, 2004
    Inventors: W Robert Addington, Robert E Stephens, Stuart P Miller
  • Publication number: 20040098788
    Abstract: An adjustable tensioning strap is mounted in a glove worn on the bowling hand and connecting the glove finger tip and an anchor point proximate the wrist or palm. The tensioning strap, from the finger tip to the anchor point, is held adjacent the glove lining by one or more transverse support straps so when placed on the hand and with tension applied to the tensioning strap, the tensioning strap is held or forced by the transverse support straps toward and substantially adjacent the bowler's finger and palm.
    Type: Application
    Filed: November 18, 2003
    Publication date: May 27, 2004
    Inventors: Randall A. Addington, W. Robert Addington
  • Patent number: 6679249
    Abstract: An apparatus and method for treatment of a patient having a pulmonary disease involving chronic obstruction of the airways includes a container having therein a chamber containing a composition of L-tartrate in a pharmaceutically acceptable carrier; an opening connected to the chamber so as to provide an outlet therefor, the opening sized for producing droplets of a predetermined size range responsive to the composition being motivated from the chamber through the opening; and a source of motivating force connected with the chamber so as to motivate the composition through the opening to thereby cause nebulization of the composition. A treatment kit comprises the container described and a mouthpiece connectable to the container so as to be in fluid connection with the opening and downstream therefrom to thereby convey the nebulized composition into a patient's mouth to thereby facilitate oral inhalation of the nebulized composition by the patient.
    Type: Grant
    Filed: August 30, 2001
    Date of Patent: January 20, 2004
    Assignee: Pneumoflex Systems, L.L.C.
    Inventors: W. Robert Addington, Robert E. Stephens, Stuart P. Miller
  • Patent number: 6658669
    Abstract: An adjustable tensioning strap is mounted in a glove worn on the bowling hand and connecting the glove finger tip and an anchor point proximate the wrist or palm. The tensioning strap, from the finger tip to the anchor point, is held adjacent the glove lining so when placed on the hand and with tension applied to the tensioning strap, the tensioning strap is held or forced by the glove toward and substantially adjacent the bowler's finger and palm.
    Type: Grant
    Filed: July 9, 2002
    Date of Patent: December 9, 2003
    Inventors: Randall A. Addington, W. Robert Addington, W. Robert Addington, II, Joel I. Rosenblatt
  • Patent number: 6655376
    Abstract: Whether a post surgery intubated patient is at risk for aspiration-based pneumonia is determined by requiring the patient to inhale an aerosol of tartaric acid that will stimulate a sensory innervation of the patient's larynx, if functionally recovered, thereby causing the patient to cough. The resulting cough or lack of cough is graded to determine whether the patient is at risk for pneumonia caused by the aspiration of matter present in the patient's mouth. In a further embodiment, the inability or difficulty of a patient to voluntarily expel potentially threatening fluid and matter from the patient's airway can be remedied by repeated applications of the aerosol chemostimulant spray.
    Type: Grant
    Filed: November 18, 1999
    Date of Patent: December 2, 2003
    Assignee: Pneumoflex Systems L.L.C.
    Inventors: W. Robert Addington, Robert E. Stephens
  • Patent number: 6581605
    Abstract: Whether a (stroke) patient is at risk for oral or pharyngeal dysphagia is determined by conducting a cough-based screening process for clinically evaluating the patient's swallow. The cough-based screening methodology is able to identify those patients who require a modified barium swallow test in order to rule out aspiration, and which patients do not need a modified barium swallow test. In accordance with the process the patient attempts to cough voluntarily. If the patient is unable to cough voluntarily, the patient is required to inhale an aerosol that stimulates a sensory innervation of the patient's larynx, thereby causing the patient to cough. The resulting cough is graded to determine whether the patient is at risk to a prescribed physiological condition, in particular pneumonia. The cough tests are supplemented by monitoring the ability of the patient to hold water in the patient's mouth for a prescribed period of time.
    Type: Grant
    Filed: December 11, 2000
    Date of Patent: June 24, 2003
    Assignee: Pneumoflex Systems L.L.C.
    Inventors: W. Robert Addington, Robin R. Ockey, Robert E. Stephens
  • Patent number: 6568397
    Abstract: The injection of an aerosol containing a chemostimulant into a patient's throat to stimulate nociceptor (irritant) and c-fibre receptors is augmented by the inclusion of a medically safe and accepted contrast substance, such as barium. The addition of a contrast substance to the aerosol allows fluoroscopic observation of the patient's (larynx) response, to facilitate a medical practitioner's identification of whether the patient is at risk to one or more abnormal physiological conditions, such as oral or pharyngeal dysphagia, and pneumonia.
    Type: Grant
    Filed: March 1, 2001
    Date of Patent: May 27, 2003
    Assignee: Pneumoflex Systems L.L.C.
    Inventors: W. Robert Addington, Robert E. Stephens, Stuart P. Miller
  • Patent number: 6561195
    Abstract: A laryngoscope-associated arrangement provides for focused delivery of a chemostimulant from a nebulizer through a delivery conduit to a patient's larynx to allow a practitioner to directly observe the function of the patient's larynx during the course of delivery of the chemostimulant. This not only provides the practitioner with a visualization of whether the patient's laryngeal vestibule is functioning properly, but allows the practitioner to be satisfied that the chemostimulant is accurately delivered to the intended region of interest.
    Type: Grant
    Filed: March 26, 2001
    Date of Patent: May 13, 2003
    Assignee: Pneumoflex Systems L.L.C.
    Inventors: W. Robert Addington, Robert E. Stephens, Stuart P. Miller
  • Publication number: 20020104529
    Abstract: Whether a post surgery intubated patient is at risk for aspiration-based pneumonia is determined by requiring the patient to inhale an aerosol of tartaric acid that will stimulate a sensory innervation of the patient's larynx, if functionally recovered, thereby causing the patient to cough. The resulting cough or lack of cough is graded to determine whether the patient is at risk for pneumonia caused by the aspiration of matter present in the patient's mouth. In a further embodiment, the inability or difficulty of a patient to voluntarily expel potentially threatening fluid and matter from the patient's airway can be remedied by repeated applications of the aerosol chemostimulant spray.
    Type: Application
    Filed: November 18, 1999
    Publication date: August 8, 2002
    Inventors: W. ROBERT ADDINGTON, ROBERT E. STEPHENS
  • Publication number: 20020100476
    Abstract: An apparatus and method for treatment of a patient having a pulmonary disease involving chronic obstruction of the airways includes a container having therein a chamber containing a composition of L-tartrate in a pharmaceutically acceptable carrier; an opening connected to the chamber so as to provide an outlet therefor, the opening sized for producing droplets of a predetermined size range responsive to the composition being motivated from the chamber through the opening; and a source of motivating force connected with the chamber so as to motivate the composition through the opening to thereby cause nebulization of the composition. A treatment kit comprises the container described and a mouthpiece connectable to the container so as to be in fluid connection with the opening and downstream therefrom to thereby convey the nebulized composition into a patient's mouth to thereby facilitate oral inhalation of the nebulized composition by the patient.
    Type: Application
    Filed: August 30, 2001
    Publication date: August 1, 2002
    Inventors: W. Robert Addington, Robert E. Stephens, Stuart P. Miller
  • Publication number: 20010050086
    Abstract: A laryngoscope-associated arrangement provides for focused delivery of a chemostimulant from a nebulizer through a delivery conduit to a patient's larynx to allow a practitioner to directly observe the function of the patient's larynx during the course of delivery of the chemostimulant. This not only provides the practitioner with a visualization of whether the patient's laryngeal vestibule is functioning properly, but allows the practitioner to be satisfied that the chemostimulant is accurately delivered to the intended region of interest.
    Type: Application
    Filed: March 26, 2001
    Publication date: December 13, 2001
    Applicant: Pneumoflex Systems, L.L.C.
    Inventors: W. Robert Addington, Robert E. Stephens, Stuart P. Miller
  • Publication number: 20010023698
    Abstract: The injection of an aerosol containing a chemostimulant into a patient's throat to stimulate nociceptor (irritant) and c-fiber receptors is augmented by the inclusion of a medically safe and accepted contrast substance, such as barium. The addition of a contrast substance to the aerosol allows fluoroscopic observation of the patient's (larynx) response, to facilitate a medical practitioner's identification of whether the patient is at risk to one or more abnormal physiological conditions, such as oral or pharyngeal dysphagia, and pneumonia.
    Type: Application
    Filed: March 1, 2001
    Publication date: September 27, 2001
    Applicant: Pneumoflex Systems, Inc.
    Inventors: W. Robert Addington, Robert E. Stephens, Stuart P. Miller
  • Patent number: 6267729
    Abstract: Whether a (stroke) patient is at risk for oral or pharyngeal dysphagia is determined by conducting a cough-based screening process for clinically evaluating the patient's swallow. The cough-based screening methodology is able to identify those patients who require a modified barium swallow test in order to rule out aspiration, and which patients do not need a modified barium swallow test. In accordance with the process the patient attempts to cough voluntarily. If the patient is unable to cough voluntarily, the patient is required to inhale an aerosol that stimulates a sensory innervation of the patient's larynx, thereby causing the patient to cough. The resulting cough is graded to determine whether the patient is at risk to a prescribed physiological condition, in particular pneumonia. The cough tests are supplemented by monitoring the ability of the patient to hold water in the patient's mouth for a prescribed period of time.
    Type: Grant
    Filed: December 31, 1998
    Date of Patent: July 31, 2001
    Assignee: Pneumoflex Systems, Inc.
    Inventors: W. Robert Addington, Robin R. Ockey, Robert E. Stephens
  • Publication number: 20010003143
    Abstract: Whether a (stroke) patient is at risk for oral or pharyngeal dysphagia is determined by conducting a cough-based screening process for clinically evaluating the patient's swallow. The cough-based screening methodology is able to identify those patients who require a modified barium swallow test in order to rule out aspiration, and which patients do not need a modified barium swallow test. In accordance with the process the patient attempts to cough voluntarily. If the patient is unable to cough voluntarily, the patient is required to inhale an aerosol that stimulates a sensory innervation of the patient's larynx, thereby causing the patient to cough. The resulting cough is graded to determine whether the patient is at risk to a prescribed physiological condition, in particular pneumonia. The cough tests are supplemented by monitoring the ability of the patient to hold water in the patient's mouth for a prescribed period of time.
    Type: Application
    Filed: December 12, 2000
    Publication date: June 7, 2001
    Inventors: W. Robert Addington, Stuart P. Miller, Roben R. Ockey, Robert E. Stephens
  • Patent number: 6004268
    Abstract: Whether a post surgery intubated patient is at risk for aspiration-based pneumonia is determined by requiring the patient to inhale an aerosol of tartaric acid that will stimulate a sensory innervation of the patient's larynx, if functionally recovered, thereby causing the patient to cough. The resulting cough or lack of cough is graded to determine whether the patient is at risk for pneumonia caused by the aspiration of matter present in the patient's mouth. In a further embodiment, the inability or difficulty of a patient to voluntarily expel potentially threatening fluid and matter from the patient's airway can be remedied by repeated applications of the aerosol chemostimulant spray.
    Type: Grant
    Filed: April 21, 1998
    Date of Patent: December 21, 1999
    Inventors: W. Robert Addington, Robert E. Stephens
  • Patent number: 5904656
    Abstract: Whether a (stroke) patient is at risk for oral or pharyngeal dysphagia is determined by conducting a cough-based screening process for clinically evaluating the patient's swallow. The cough-based screening methodology is able to identify those patients who require a modified barium swallow test in order to rule out aspiration, and which patients do not need a modified barium swallow test. In accordance with the process the patient attempts to cough voluntarily. If the patient is unable to cough voluntarily, the patient is required to inhale an aerosol that stimulates a sensory innervation of the patient's larynx, thereby causing the patient to cough. The resulting cough is graded to determine whether the patient is at risk to a prescribed physiological condition, in particular pneumonia. The cough tests are supplemented by monitoring the ability of the patient to hold water in the patient's mouth for a prescribed period of time.
    Type: Grant
    Filed: June 30, 1997
    Date of Patent: May 18, 1999
    Assignee: Dysphagia Systems, Inc.
    Inventors: W. Robert Addington, Robin R. Ockey, Robert E. Stephens
  • Patent number: 5678563
    Abstract: Whether a (stroke) patient is at risk for oral or pharyngeal dysphagia is determined by conducting a cough-based screening process for clinically evaluating the patient's swallow. The cough-based screening methodology is able to identify those patients who require a modified barium swallow test in order to rule out aspiration, and which patients do not need a modified barium swallow test. In accordance with the process the patient attempts to cough voluntarily. If the patient is unable to cough voluntarily, the patient is required to inhale an aerosol that stimulates a sensory innervation of the patient's larynx, thereby causing the patient to cough. The resulting cough is graded to determine whether the patient is at risk to a prescribed physiological condition, in particular pneumonia. The cough tests are supplemented by monitoring the ability of the patient to hold water in the patient's mouth for a prescribed period of time.
    Type: Grant
    Filed: November 16, 1995
    Date of Patent: October 21, 1997
    Inventors: W. Robert Addington, Stuart P. Miller, Robin R. Ockey